The main goal of this work is to locate and evaluate molecular targets for brain cancers, starting with glioblastoma. This project serves as a pilot for larger cancer re-sequencing projects. We have teamed with the Venter Institute and its associated Joint Technology Center to perform state-of-the-art and low cost sequencing using their SNP detection pipeline. For our first specific aim, we will re-sequence all known kinase domains in the cancer genomes of 30 glioblastomas. Once a kinase domain mutation is detected we expand our analysis to the entire gene in 50 additional glioblastomas and a panel of other brain cancers, including pediatric glioblastomas and medulloblastomas. In our preliminary analysis of the first 40 kinase genes, novel tyrosine receptor kinase mutations were found in FGFR1 and PDGFRA. We have also found additional mutations in PIK3CA in adult and pediatric glioblastoma.
In specific aim 2, we propose to create a high-resolution copy number map of our 30 glioblastomas using Digital Karyotyping, so we can evaluate in the same samples point mutations, amplifications and deletions. We have completed Digital Karyotyping in 8 glioblastomas, and previously published on using this powerful technique to find a developmental gene genomic amplification in medulloblastoma.
In specific aim 3 we will functionally evaluate the mutations we find with frequency greater than 10%, starting with two kinase mutations we have already found in glioblastoma. We will create a model system of the mutation in cell lines and determine the target of altered phosphorylation and if the cell-cycle, apoptosis and/or invasion are altered. To ensure rapid reporting and integration of our work into larger efforts we propose an online database and reporting for our fourth and final specific aim. Glioblastomas have poor survival and new treatments are needed. Our long-term goal is to choose the best molecular targets from this systematic analysis and determine if inhibition of these new mutations will be a successful therapeutic strategy. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS052507-02
Application #
7273719
Study Section
Cancer Genetics Study Section (CG)
Program Officer
Fountain, Jane W
Project Start
2006-08-09
Project End
2010-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
2
Fiscal Year
2007
Total Cost
$645,473
Indirect Cost
Name
Johns Hopkins University
Department
Neurology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Yamashita, A S; Baia, G S; Ho, J S Y et al. (2014) Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors. J Neurooncol 118:83-92
Bai, Ren-Yuan; Staedtke, Verena; Lidov, Hart G et al. (2012) OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells. Cancer Res 72:5988-6001
Joshi, Avadhut D; Loilome, Watcharin; Siu, I-Mei et al. (2012) Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy. PLoS One 7:e44372
Weber, Genevieve L; Parat, Marie-Odile; Binder, Zev A et al. (2011) Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells. Oncotarget 2:833-49
Qiao, Yuan; Huang, Xin; Nimmagadda, Sridhar et al. (2011) A robust approach to enhance tumor-selective accumulation of nanoparticles. Oncotarget 2:59-68
Bai, Ren-Yuan; Staedtke, Verena; Riggins, Gregory J (2011) Molecular targeting of glioblastoma: Drug discovery and therapies. Trends Mol Med 17:301-312
Joshi, Avadhut D; Parsons, D Williams; Velculescu, Victor E et al. (2011) Sodium ion channel mutations in glioblastoma patients correlate with shorter survival. Mol Cancer 10:17
Bai, Ren-Yuan; Staedtke, Verena; Aprhys, Colette M et al. (2011) Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. Neuro Oncol 13:974-82
Rao, Shailaja K; Edwards, Jennifer; Joshi, Avadhut D et al. (2010) A survey of glioblastoma genomic amplifications and deletions. J Neurooncol 96:169-79
Seltzer, Meghan J; Bennett, Bryson D; Joshi, Avadhut D et al. (2010) Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res 70:8981-7

Showing the most recent 10 out of 19 publications